Get started
Author

Amy L. Adlard

Observed names: AL Adlard, Amy Adlard
ORCID: 0000-0002-6685-8718
Observed ORCID: 0000-0002-6685-8718
OpenAlex ID: A5030702116
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
2014 · Simon J. Dovedi, Amy L. Adlard, et al. · Cancer Research · 1,315
PDF
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
2012 · Simon J. Dovedi, Monique H. M. Melis, et al. · Blood · 145
A novel systemically administered toll‐like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
2014 · Amy L. Adlard, Simon J. Dovedi, et al. · International Journal of Cancer · 49
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
2016 · Simon J. Dovedi, Amy L. Adlard, et al. · Oncotarget · 29
PDF
The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
2014 · Simon Dovedi, Amy Adlard, et al. · Journal for ImmunoTherapy of Cancer · 4
PDF
Supplemental Figures 1 - 7 from Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
2023 · Simon J. Dovedi, Amy L. Adlard, et al.
PDF
Supplemental Figures 1 - 7 from Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
2023 · Simon J. Dovedi, Amy L. Adlard, et al.
Data from Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
2023 · Simon J. Dovedi, Amy L. Adlard, et al.
Data from Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
2023 · Simon J. Dovedi, Amy L. Adlard, et al.
Adaptive resistance to fractionated radiation therapy can be overcome by concurrent PDL1 blockade
2014 · SJ Dovedi, AL Adlard, et al. · Cancer Research
Works count: 11
Citation count: 1,542
H-index: 4
I10-index: 4
Year
Topic
Type